The biobank is an ongoing prospective study that until now involved approximately 30,000 individuals. We implemented the largest national biobank comprising phenotypically well characterized biological samples of subjects that represent the general population, collected under a strict handling and storage protocol, from our cohorts but also representative national samples recruited at primary health care centers, and patients with gastric cancer, colon cancer and viral hepatitis. The biobank keeps approximately 150,000 samples of serum, plasma and approximately 3000 teeth. DNA samples are available from most cohort patients.

 

 

 

 

Calendar

Weekly Publication

Quantifying the burden of stillbirths before 28 weeks of completed gestational age in high-income countries: a population-based study of 19 European countries.
Lancet
Read More